Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenetics of Tacrolimus-Ketoconazole Interaction in Kidney Transplant
NCT01288521Phase 4Completed
- Start
- Oct 2008
- Primary completion
- Jun 2011
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tacrolimus in kidney transplantation (2 arms). Primary endpoint: Tacrolimus Bioavailability (F) at 2 weeks. Started Oct 2008; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01288521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288521.